Agalimmune Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour (NCT03593226) | Agalimmune Ltd. | 2018-11-30 |
Track Agalimmune Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.